A model for the future conduct of pharmacovigilance

被引：79

作者：

Waller, PC ^{[1
]}

Evans, SJW ^{[1
]}

机构：

[1] Med Control Agcy, Post Licensing Div, London, England

来源：

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2003年 / 12卷 / 01期

关键词：

pharmacovigilance; drug safety; strategy; model;

D O I：

10.1002/pds.773

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

A scientific model to support excellence in pharmacovigilance has been developed from first principles by brainstorming sessions and discussions with experts in the field. The model represents a long-term vision of how pharmacovigilance could be conducted in the future. So far it has been developed without any consideration of constraints such as resources or the need for legislative change. Although the vision is holistic, it would be possible to test and implement parts of the model in a piecemeal fashion. Copyright (C) 2002 John Wiley Sons, Ltd.

引用

页码：17 / 29

页数：13

共 22 条

[1]

BURLEY D M, 1988, Pharmaceutical Medicine (London), V3, P231

[2]

*CIOMS 3 5 WORK GR, 1999, GUID PREP COR CLIN S

[3]

CIOMS IV Working Group, 1998, BEN RISK BAL MARK DR

[4] Monitoring the safety of over the counter drugs - We need a better way than spontaneous reports [J].

Clark, D ;

Layton, D ;

Shakir, SAW .

BMJ-BRITISH MEDICAL JOURNAL, 2001, 323 (7315) :706-707

[5]

*COMM SAF MED MED, 2000, CURR PROBL PHARMACOV, V26, P8

[6]

DARCY PF, 1996, P 3 INT C HARM YOK

[7]

GRAHAMESMITH DG, 1987, ADVERSE DRUG REACT, P201

[8] Incidence of adverse drug reactions in hospitalized patients - A meta-analysis of prospective studies [J].

Lazarou, J ;

Pomeranz, BH ;

Corey, PN .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (15) :1200-1205

[9]

Lilford RJ, 1998, BMJ-BRIT MED J, V317, P405

[10] Prescription-event monitoring - recent progress and future horizons [J].

Mann, RD .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 46 (03) :195-201

← 1 2 3 →